Literature DB >> 22100394

UG repeats/TDP-43 interactions near 5' splice sites exert unpredictable effects on splicing modulation.

Monica Passoni1, Laura De Conti, Marco Baralle, Emanuele Buratti.   

Abstract

TDP-43 is a nuclear protein implicated in the pathogenesis of several neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration, with broad involvement in numerous stages of RNA processing ranging from transcription to translation. In diseased neurons, TDP-43 mostly aggregates in the cytoplasm, suggesting that a loss of protein function in the nucleus may play an important role in neurodegeneration. A better understanding of TDP-43 general nuclear functions is therefore an essential step to evaluate this possibility. Presently, the TDP-43 best-characterized functional property is its ability to modulate pre-mRNA splicing when binding in proximity of 3'SS acceptor sequences. In this work, using a variety of artificial and natural splicing substrates, we have investigated the effects of TDP-43 binding to UG repeats in the vicinity of 5'SS donor sequences. In general, our results show that UG repeats are not powerful splicing regulatory elements when located near to exonic 5'SS sequences. However, in cases like the BRCA1, ETF1, and RXRG genes, TDP-43 binding to natural UG-repeated sequences can act as either an activator or a suppressor of 5'SS recognition, depending on splice site strength and on the presence of additional splicing regulatory sequences. The results of this analysis suggest that a role of UG repeats/TDP-43 in 5'SS recognition may exists and may become critical in the presence of mutations that weaken the 5'SS. The general rule that can be drawn at the moment is that the importance of UG repeats near 5' splice sites should always be experimentally validated on a case-by-case basis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100394     DOI: 10.1016/j.jmb.2011.11.003

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

Review 1.  Misregulated RNA processing in amyotrophic lateral sclerosis.

Authors:  Magdalini Polymenidou; Clotilde Lagier-Tourenne; Kasey R Hutt; C Frank Bennett; Don W Cleveland; Gene W Yeo
Journal:  Brain Res       Date:  2012-03-03       Impact factor: 3.252

2.  Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.

Authors:  Jianlan Gu; Feng Chen; Khalid Iqbal; Cheng-Xin Gong; Xinglong Wang; Fei Liu
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

3.  Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?

Authors:  Christopher J Donnelly; Jonathan C Grima; Rita Sattler
Journal:  Neurodegener Dis Manag       Date:  2014

Review 4.  Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis.

Authors:  S Bräuer; V Zimyanin; A Hermann
Journal:  J Neural Transm (Vienna)       Date:  2018-02-08       Impact factor: 3.575

Review 5.  Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder.

Authors:  Fen-Biao Gao; Sandra Almeida; Rodrigo Lopez-Gonzalez
Journal:  EMBO J       Date:  2017-09-15       Impact factor: 14.012

6.  RNA structure replaces the need for U2AF2 in splicing.

Authors:  Chien-Ling Lin; Allison J Taggart; Kian Huat Lim; Kamil J Cygan; Luciana Ferraris; Robbert Creton; Yen-Tsung Huang; William G Fairbrother
Journal:  Genome Res       Date:  2015-11-13       Impact factor: 9.043

7.  Functional characterization of the common c.-32-13T>G mutation of GAA gene: identification of potential therapeutic agents.

Authors:  Andrea Dardis; Irene Zanin; Stefania Zampieri; Cristiana Stuani; Annalisa Pianta; Milena Romanello; Francisco E Baralle; Bruno Bembi; Emanuele Buratti
Journal:  Nucleic Acids Res       Date:  2013-10-22       Impact factor: 16.971

8.  Characterizing TDP-43 interaction with its RNA targets.

Authors:  Amit Bhardwaj; Michael P Myers; Emanuele Buratti; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2013-03-21       Impact factor: 16.971

9.  TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways.

Authors:  Laura De Conti; Maureen V Akinyi; Ramiro Mendoza-Maldonado; Maurizio Romano; Marco Baralle; Emanuele Buratti
Journal:  Nucleic Acids Res       Date:  2015-08-10       Impact factor: 16.971

10.  Redirecting splicing with bifunctional oligonucleotides.

Authors:  Jean-Philippe Brosseau; Jean-François Lucier; Andrée-Anne Lamarche; Lulzim Shkreta; Daniel Gendron; Elvy Lapointe; Philippe Thibault; Eric Paquet; Jean-Pierre Perreault; Sherif Abou Elela; Benoit Chabot
Journal:  Nucleic Acids Res       Date:  2013-12-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.